+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pulmonary Embolism"

Pulmonary Embolism Global Market Report 2024 - Product Thumbnail Image

Pulmonary Embolism Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Deep Vein Thrombosis Global Market Report 2024 - Product Thumbnail Image

Deep Vein Thrombosis Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Interventional Cardiology: Atherectomy and Thromboembolectomy - Product Thumbnail Image

Interventional Cardiology: Atherectomy and Thromboembolectomy

  • Report
  • April 2018
  • 100 Pages
  • Global
From
Interventional Cardiology Vascular Stents - Product Thumbnail Image

Interventional Cardiology Vascular Stents

  • Report
  • January 2018
  • 120 Pages
  • Global
From
Mastering Structural Heart Disease. Edition No. 1 - Product Thumbnail Image

Mastering Structural Heart Disease. Edition No. 1

  • Book
  • February 2023
  • 672 Pages
Loading Indicator

Pulmonary embolism (PE) is a medical condition in which a blood clot blocks one or more arteries in the lungs. It is a serious complication of deep vein thrombosis (DVT), a condition in which a blood clot forms in a deep vein, usually in the leg. PE is a major cause of death in cardiology, and is estimated to affect up to 600,000 people in the United States each year. Symptoms of PE include chest pain, shortness of breath, and coughing up blood. Diagnosis is typically made through imaging tests such as computed tomography (CT) scans or echocardiograms. Treatment typically involves anticoagulant medications to prevent further clotting, and in some cases, clot-dissolving medications or surgery. Companies in the Pulmonary Embolism market include Boehringer Ingelheim, Bayer, Daiichi Sankyo, Pfizer, and Bristol-Myers Squibb. Show Less Read more